Measuring the quality of renal care: Things to keep in mind when selecting and using quality indicators

Nephrology Dialysis Transplantation

Volumn 29, Issue 8, 2014, Pages 1460-1467

  Van Der Veer, Sabine N ^a,b   Van Biesen, Wim ^b   Couchoud, Cécile ^c   Tomson, Charles R V ^d   Jager, Kitty J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c AGENCE DE LA BIOMÉDECINE   (France)

^d SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Nephrology; Quality indicators; Quality of health care

Indexed keywords

CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; END STAGE RENAL DISEASE; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HEALTH SERVICE; HEMODIALYSIS; HUMAN; KIDNEY TRANSPLANTATION; MEDICAL DECISION MAKING; NEPHROLOGY; PERFORMANCE MEASUREMENT SYSTEM; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; TREATMENT OUTCOME;

NEPHROLOGY; QUALITY INDICATORS; QUALITY OF HEALTH CARE;

HUMANS; NEPHROLOGY; QUALITY ASSURANCE, HEALTH CARE; QUALITY INDICATORS, HEALTH CARE;

EID: 84905053901     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft473     Document Type: Review

References (45)

1. Dialysis Outcomes and Practice Patterns Study program (2 September 2013, date last accessed)
2. Tomson C, Ford D, Ansell D. The UK Renal Registry: An overview. Br J Hosp Med (Lond) 2008; 69: 548-549
3. van der Sande FM, Kooman JP, Ikenroth LJ et al. A system of quality management in dialysis. Semin Dial 2003; 16: 453-457
4. Stoffel MP, Barth C, Lauterbach KWet al. Evidence-based medical quality management in dialysis-Part I: Routine implementation of QiN, a German quality management system. Clin Nephrol 2004; 62: 208-218
5. Consumer Assessment of Healthcare Providers and Systems (CAHPS). In-center Hemodialysis survey. www.cahps.ahrq.gov/hemodialysis (19 February 2013, date last accessed).
6. Fishbane S, Miller I, Wagner JD et al. Changes to the end-stage renal disease quality incentive program. Kidney Int 2012; 81: 1167-1171
7. Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q 2005; 83: 691-729
8. Mainz J. Defining and classifying clinical indicators for quality improvement. Int J Qual Health Care 2003; 15: 523-530
9. Lilford R, Mohammed MA, Spiegelhalter D et al. Use and misuse of process and outcome data in managing performance of acute medical care: Avoiding institutional stigma. Lancet 2004; 363: 1147-1154
10. Manns B, Owen WF, Jr,WinkelmayerWC et al. Surrogate markers in clinical studies: Problems solved or created? Am J Kidney Dis 2006; 48: 159-166
11. Smith KA, Hayward RA. Performance measurement in chronic kidney disease. J Am Soc Nephrol 2011; 22: 225-234
12. Iseki K, Iseki C, Ikemiya Y et al. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996; 49: 800-805
13. Atkins RC, Briganti EM, Lewis JB et al. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. Am J Kidney Dis 2005; 45: 281-287
14. Cravedi P, Ruggenenti P, Remuzzi G. Proteinuria should be used as a surrogate in CKD. Nat Rev Nephrol 2012; 8: 301-306
15. Thompson A. Proteinuria as a surrogate end point-more data are needed. Nat Rev Nephrol 2012; 8: 306-309
16. Lindholm LH, Ibsen H, Dahlof B et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. Lancet 2002; 359: 1004-1010
17. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861-869
18. Mountford J, Shojania KG. Refocusing quality measurement to best support quality improvement: Local ownership of quality measurement by clinicians. BMJ Qual Saf 2012; 21: 519-523
19. Pringle M, Wilson T, Grol R. Measuring 'goodness' in individuals and healthcare systems. BMJ 2002; 325: 704-707
20. Freeman T. Using performance indicators to improve health care quality in the public sector: A review of the literature. Health Serv Manage Res 2002; 15: 126-137
21. Solberg LI, Mosser G, McDonald S. The three faces of performance measurement: Improvement, accountability, and research. Jt Comm J Qual Improv 1997; 23: 135-147
22. Centers for Medicare and Medicaid Services Clinical Performance Measurement project. http://www.cms.gov/Medicare/End-Stage-Renal-Disease/ CPMProject (8 March 2004, date last accessed).
23. American Medical Association-Convened Physician Consortium for Performance Improvement. Adult Kidney Disease. Performance Measurement set; Measures for Accountability. Chicago: American Medical Association, 2011
24. Chassin MR, Loeb JM, Schmaltz SP et al. Accountability measures-using measurement to promote quality improvement. N Engl J Med 2010; 363: 683-688
25. Vachharajani TJ, Moossavi S, Jordan Jr. et al. Re-evaluating the fistula first initiative in octogenarians on hemodialysis. Clin J Am Soc Nephrol 2011; 6: 1663-1667
26. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 2003; 41: I-91
27. van der Veer SN, Jager KJ, Nache AM et al. Translating knowledge on best practice into improving quality of RRT care: A systematic review of implementation strategies. Kidney Int 2011; 80: 1021-1034
28. Tawadrous D, Shariff SZ, Haynes RB et al. Use of clinical decision support systems for kidney-related drug prescribing: A systematic review. Am J Kidney Dis 2011; 58: 903-914
29. Spiegel B, Bolus R, Desai AA et al. Dialysis practices that distinguish facilities with below-versus above-expected mortality. Clin J Am Soc Nephrol 2010; 5: 2024-2033.
30. Spiegel BM, Bolus R, Desai AA et al. Dialysis practices that distinguish top-versus bottom-performing facilities by hemoglobin outcomes. Am J Kidney Dis 2010; 56: 86-94
31. Kotter T, Blozik E, Scherer M. Methods for the guideline-based development of quality indicators-A systematic review. Implement Sci 2012; 7: 21
32. Guyatt GH, Oxman AD, Kunz R et al. Going from evidence to recommendations. BMJ 2008; 336: 1049-1051
33. Howick J, Glasziou P, Aronson JK. Evidence-based mechanistic reasoning. J R Soc Med 2010; 103: 433-441
34. van Zuilen AD, Bots ML, Dulger A et al. Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int 2012; 82: 710-717
35. Baigent C, Landray MJ, Reith C et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): A randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192
36. Palmer SC, Craig JC, Navaneethan SD et al. Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-Analysis. Ann Intern Med 2012; 157: 263-275
37. Jager KJ, Stel VS, Zoccali C et al. The issue of studying the effect of interventions in renal replacement therapy-To what extent may we be deceived by selection and competing risk? Nephrol Dial Transplant 2010; 25: 3836-3839
38. Doran T, Fullwood C, Gravelle H et al. Pay-for-performance programs in family practices in the United Kingdom. N Engl J Med 2006; 355: 375-384
39. Rosenbaum L, Shrank WH. Taking our medicine-improving adherence in the accountability era. N Engl J Med 2013; 369: 694-695
40. European Nephrology Quality Improvement Network-NephroQUEST. http://www.nephro-quest.eu (6 February 2013, date last accessed)
41. Plantinga LC, Fink NE, Jaar BG et al. Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients. J Am Soc Nephrol 2004; 15: 3144-3153
42. Sugarman JR, Frederick PR, Frankenfield DL et al. Developing clinical performance measures based on the Dialysis Outcomes Quality Initiative Clinical Practice Guidelines: Process, outcomes, and implications. Am J Kidney Dis 2003; 42: 806-812
43. Tangri N, Tighiouart H, Meyer KB et al. Both patient and facility contribute to achieving the centers for medicare and medicaid services' pay-for-performance target for dialysis adequacy. J Am Soc Nephrol 2011; 22: 2296-2302
44. Collier T, Steenkamp R, Tomson C et al. Patterns and effects of missing comorbidity data for patients starting renal replacement therapy in England, Wales and Northern Ireland. Nephrol Dial Transplant 2011; 26: 3651-3658
45. Boyd CM, Darer J, Boult C et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 2005; 294: 716-724